CHICAGO - When action movie star Chuck Norris earlier this month filed suit against firms involved in the distribution of gadolinium-based contrast agents, he put a human face on the gadolinium retention issue. MRI safety expert Dr. Emanuel Kanal of the University of Pittsburgh discusses the latest findings in what's known about gadolinium safety in this video.
Video from RSNA 2017: Gadolinium retention debate takes center stage
Nov 27, 2017
Latest in MRI
Simulated contrast-enhanced MRI helps assess prostate cancer
January 15, 2025
ML model using CCTA, MRI data predicts MACE in cardiac patients
January 14, 2025
Genetic testing, risk assessment tied to more breast MRI uptake
January 13, 2025